Study population The study population included adults (aged 18 years) with body mass index (BMI) 27 kg/m with 1 obesity-related complication or BMI 30 kg/m, who initiated tirzepatide (Zepbound ) or semaglutide (Wegovy ) for obesity management between December 1, 2023, and June 30, 2024
I've seen too many people get caught up in flashy marketing without considering what really matters: medical expertise, safety protocols, and personalized care
My Take as a Diabetes Dietitian I'm genuinely excited about retatrutide
Following patent expiration, generic formulations entered the market, and cash-pay prices dropped to approximately $25 to $100 per month through discount pharmacies, manufacturer programs, and compounding pharmacies offering liraglutide preparations
Free Rad Biol Med 2012;52(10):2128-2141